Travoprost
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00287 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | visceral calciphylaxis | KG + DL |
| 2 | arterial thoracic outlet syndrome | KG + DL |
| 3 | venous thoracic outlet syndrome | KG + DL |
| 4 | neurogenic thoracic outlet syndrome | KG + DL |
| 5 | vascular disease | KG + DL |
| 6 | angiodysplasia of stomach | KG + DL |
| 7 | blue toe syndrome | KG + DL |
| 8 | idiopathic spontaneous coronary artery dissection | KG + DL |
| 9 | lymphangiectasis | KG + DL |
| 10 | hemangioendothelioma | KG + DL |
| 11 | hypotrichosis simplex of the scalp | KG + DL |
| 12 | atheroembolism of kidney | KG + DL |
| 13 | arterial dissection-lentiginosis syndrome | KG + DL |
| 14 | congenital hypotrichosis milia | KG + DL |
| 15 | diffuse alopecia areata | KG + DL |
| 16 | alopecia | KG + DL |
| 17 | hypertrichosis (disease) | KG + DL |
| 18 | primary hereditary glaucoma | KG + DL |
| 19 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 20 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 21 | isolated genetic hair shaft abnormality | KG + DL |
| 22 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 23 | pulmonary arterial hypertension | KG + DL |
| 24 | pulmonary arteriovenous malformation (disease) | KG + DL |
| 25 | pulmonary arterial hypertension associated with congenital heart disease | KG + DL |
| 26 | pulmonary arterial hypertension associated with connective tissue disease | KG + DL |
| 27 | pulmonary arterial hypertension associated with chronic hemolytic anemia | KG + DL |
| 28 | pulmonary arterial hypertension associated with schistosomiasis | KG + DL |
| 29 | pulmonary arterial hypertension associated with HIV infection | KG + DL |
| 30 | genetic alopecia | KG + DL |
| 31 | persistent fetal circulation syndrome | KG + DL |
| 32 | respiratory failure | KG + DL |
| 33 | subarachnoid hemorrhage (disease) | KG + DL |
| 34 | pseudopelade of Brocq | KG + DL |
| 35 | 16q24.1 microdeletion syndrome | KG + DL |
| 36 | isolated pulmonary capillaritis | KG + DL |
| 37 | primary interstitial lung disease specific to childhood | KG + DL |
| 38 | glaucoma 1, open angle | KG + DL |
| 39 | congenital alveolar capillary dysplasia | KG + DL |
| 40 | open angle glaucoma | KG + DL |
| 41 | congenital pulmonary lymphangiectasia | KG + DL |
| 42 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 43 | yellow nail syndrome | KG + DL |
| 44 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 45 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 46 | coxopodopatellar syndrome | KG + DL |
| 47 | Wyburn-Mason syndrome | KG + DL |
| 48 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 49 | Moyomoya angiopathy | KG + DL |
| 50 | idiopathic macular telangiectasia | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.